Meeting
2015 Gastrointestinal Cancers Symposium
S100P tumor-marker response to chemotherapy in patients with advanced pancreatic cancer.
Authors
Shuichi Mitsunaga
Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan
Shuichi Mitsunaga , Kumiko Umemoto , Kazuo Watanabe , Hiroyuki Okuyama , Yusuke Hashimoto , Hideaki Takahashi , Izumi Ohno , Satoshi Shimizu , Atsushi Ochiai , Masafumi Ikeda
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 265)
DOI
10.1200/jco.2015.33.3_suppl.265
Abstract #
265
Poster Bd #
A36
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Second-line chemotherapy in patients with advanced biliary tract cancer.
First Author: Naminatsu Takahara
Poster
2018 Gastrointestinal Cancers Symposium
Outcomes and characteristics of patients receiving second-line therapy for advanced pancreatic cancer.
First Author: Erica S Tsang
Poster
2017 ASCO Quality Care Symposium
Uptake and effectiveness of FOLFIRINOX for advanced pancreas cancer: A population-based study.
First Author: Safiya Karim
Poster
2017 Gastrointestinal Cancers Symposium
Effect of advanced age, elevated bilirubin, and disease extent on outcomes of unresectable pancreatic cancer (UPC) patients receiving first-line chemotherapy: A population-based study.
First Author: Hannah Marie Cherniawsky